CURRICULUM VITAE FOR ADAM IAN KAPLIN
`The Johns Hopkins University School of Medicine
`
`
`1
`
`Signature
`
` Adam Ian Kaplin
`
`
`
`4/14/17
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Date
`
`
`DEMOGRAPHIC INFORMATION
`
`
`
`
`
`Current Appointments
`
`2004- Present Chief Neuropsychiatric Consultant, Multiple Sclerosis Center of Excellence
`
`
`Department of Psychiatry and Neurology
`
`
`Johns Hopkins University School of Medicine
`
`
`Personal Data
`
`Business Address:
`
`
`
`
`
`
`
`
`
`
`Johns Hopkins Hospital
`Department of Psychiatry and Behavioral Sciences
`600 North Wolfe Street/ Meyer 121
`Baltimore, MD 21287-7121
`
`Office: (410)-614-3307
`Mobile: (410)
`
`akaplin@jhmi.edu
`
`
`
`
`
`
`
`
`
`Phone:
`
`
`
`E-mail:
`
`Education and Training
`
`
`
`1985-1988
`B.S., Biology - Magna cum laude, Yale University, New Haven, CT
`(Brandeis University 1984-85, transferred to Yale)
`
`
`
`1989-1996
`
`
`
`1989-1996
`
`
`
`1996-1997
`
`1997-2000
`
`1999-2000
`
`
`
`RESEARCH ACTIVITIES
`
`Research Training Experience
`
`Summer 1986 Summer Student Fellowship Program , National Cancer Institute-FCRC, Frederick, MD
` Laboratory of David Garfinkel, Ph.D.
`
`
`
`M.D., Johns Hopkins University School of Medicine, Baltimore, MD
`Medical Scientist Training Program
`
`Ph.D., Johns Hopkins University School of Medicine, Baltimore, MD
`Department of Neuroscience, Advisor - Solomon H. Snyder, M.D.
`
`Internship, Internal Medicine, Johns Hopkins Bayview Medical Center, Baltimore, MD
`
`Residency Training, Psychiatry, Johns Hopkins Hospital, Baltimore, MD
`
`Chief Resident, Department of Psychiatry, Johns Hopkins Hospital, Baltimore, MD
`
`Par Pharm., Inc.
`Exhibit 1007
`Page 001
`
`

`

`
`Summer 1987 Undergraduate Research Program, Cold Spring Harbor, NY
`
`
`Laboratory of David Spector, Ph.D.
`Investigation of functional significance of the in situ Sm Ag
`
`2
`
`
`
`
`1987-1988
`
`
`
`
`
`1988-1989
`
`
`
`
`
`1991-1995
`
`Undergraduate Senior Research Thesis, Yale University, New Haven, CT
`Department of Biology, Laboratory of Sidney Altman, Ph.D. (Nobel Laureate)
`Investigation of enzymatic activity of a continuous RNA construct in E. coli
`
`
`
`Assistant Researcher, Yale University School of Medicine, New Haven, CT
`Laboratory of George Palade, M.D. (Nobel Laureate)
`
`
`
`Investigation of vesicular transport and protein trafficking in mammalian cells
`
`
`
`
`
`
`
`
`
`
`Ph.D. Research Thesis, Johns Hopkins University School of Medicine, Baltimore, MD
`Laboratory of Solomon Snyder, M.D.
`Thesis: New mechanisms involved in intracellular calcium
`signaling: Novel means of activating inositol 1,4,5-trisphosphate receptors.
`
`
`
`
`
`
`
`
`Publications
`
`
`
`
`Peer Reviewed Original Research Articles
`
`1. Sztul E, Kaplin A, Saucan L, Palade G. Protein traffic between distinct plasma membrane
`domains: isolation and characterization of vesicular carriers involved in transcytosis. Cell. 1991;
`64(1): 81-9.
`
`2. Kaplin AI, Ferris CD, Voglmaier SM, Snyder SH. Purified reconstituted inositol 1, 4, 5-
`trisphosphate receptors: Thiol reagents act directly on receptor protein. J. Biol. Chem. 1994; 269:
`28972-28978.
`
`3. Cameron AM, Steiner JP, Sabatini DM, Kaplin AI, Walensky LD, Snyder SH. Immunophilin
`FK506 Binding Protein Associated with Inositol 1,4,5-Trisphosphate Receptor Modulates
`Calcium Flux. Proc. Natl. Acad. Sci. USA. 1995; 92: 1784-1788.
`
`4. Kaplin AI, Snyder SH, Linden DJ. Reduced nicotinamide adenine dinucleotide-selective
`stimulation of inositol 1,4,5-trisphosphate receptors mediates hypoxic mobilization of calcium. J.
`of Neuroscience. 1996; 16(6): 2002-2011.
`
`5. Voglmaier SM, Bembenek ME, Kaplin AI, Dorman G, Olszewski JD, Prestwich GD, Snyder
`SH. Purified inositol hexakisphosphate kinase is an ATP synthase -diphosphoinositol
`pentakisphosphate as a high-energy phosphate donor. Proc. Natl. Acad. Sci. USA. 1996; 93(9):
`4305-4310.
`
`6. Pieper AA, Brat DJ, O'Hearn E, Krug DK, Kaplin AI, Takahashi K, Greenberg JH, Ginty D,
`Molliver ME, Snyder SH. Differential neuronal localizations and dynamics of phosphorylated
`and unphosphorylated type 1 inositol 1,4,5-trisphosphate receptors. Neuroscience. 2001; 102(2):
`433-44.
`
`7. Treisman GJ, Kaplin AI. Neurologic and psychiatric complications of antiretroviral agents.
`AIDS. 2002; 16(9): 1201-15.
`
`8. Kerr DA, Barnes G, Benjamin S, Bowen JD, Cutter N, de Lateur BJ, Dietrich WD, Dowling
`MM, Griffin JW, Hummers L, Irani, D, Jorens PG, Kaplin AI, Katz JD, Krishnan C, Levy CE,
`Lucchinetti C. Proposed diagnostic criteria and nosology of acute transverse myelitis.
`Neurology. 2002; 59(4): 499-505.
`
`Par Pharm., Inc.
`Exhibit 1007
`Page 002
`
`

`

`
`
`
`
`
`
`
`
`
`9. Krishnan C, Kaplin AI, Deshpande DM, Pardo CA, Kerr DA. Transverse Myelitis:
`pathogenesis, diagnosis and treatment. Frontiers in Bioscience. 2004; 9: 1483-1499.
`
`10. Watkins CC, Boehning D, Kaplin AI, Rao M, Ferris CD, Snyder SH. Carbon monoxide
`mediates vasoactive intestinal polypeptide-associated nonadrenergic/noncholinergic
`neurotransmission. Proc Natl Acad Sci U S A. 2004; 101(8): 2631-2635.
`
`3
`
`11. Kaplin AI, Krishnan C, Deshpande DM, Pardo CA, Kerr DA. Diagnosis and Management of
`Acute Myelopathies. The Neurologist. 2004; 11(1): 2-18.
`
`12. Patterson RL, van Rossum DB, Kaplin AI, Barrow RK, Snyder SH. Inositol 1,4,5-
`triphosphate receptor / GAPDH complex augments Ca2+ release via locally derived NADH.
`Proceedings of the National Academy of Sciences (PNAS). 2005; 102(5): 1357-1359.
`
`13. Krishnan C, Kaplin AI, Graber JS, Darman JS, Kerr DA. Recurrent transverse myelitis
`following
`neurobrucellosis:
`Immunologic
`features
`and
`beneficial
`response
`to
`immunosuppression. Journal of Neurovirology. 2005; 11(2): 225-231.
`
`14. Berger JR, Cambi F, Di Rocco A, Farace J, Kaplin AI, Kerr DA, Keswani SC, Krishnan C,
`Olson SE, Zivin JA. Spinal Cord Disorders. AAN Continuum Life Long Learning in Neurology,
`2005; 11(3).
`
`15. Kaplin AI, Deshpande DM, Scott E, Krishnan C, Darman JS, Shats I, Martinez T,
`Drummond J, Dike S, Pletnikov M, Keswani SC, Moran TH, Pardo CA, Calabresi PA, Kerr DA.
`Interleukin-6
`induces
`regionally selective spinal cord
`injury
`in patients with
`the
`neuroinflammatory disorder transverse myelitis. Journal of Clinical Investigation. 2005;
`115(10): 2731-2741.
`
`16. Kaplin A, Bartner S. Reciprocal Communication between the Nervous and Immune Systems:
`crosstalk, back-talk and motivational speeches. International Review of Psychiatry. 2005; 17(6):
`439–441
`
`17. Pucak ML, Kaplin AI. Unkind cytokines: Current evidence for the potential role of cytokines
`in immune-mediated depression. International Review of Psychiatry, 2005; 17(6): 477-483.
`
`18. Krishnan C, Kaplin AI, Pardo C, Kerr DA, Keswani SC. Demyelinating disorders: update on
`transverse myelitis. Current Neurology and Neuroscience Reports. 2006; 6(3): 236-243.
`
`19. Greenberg BM, Thomas KP, Krishnan C, Kaplin AI, Calabresi PA, Kerr DA. Idiopathic
`transverse myelitis: corticosteroids, plasma exchange, or cyclophosphamide. Neurology. 2007;
`68(19):1614-1617
`
`20. Kaplin AI, Williams M. How common are the “common” neurologic disorders? Neurology.
`2007; 69(4): 410-411.
`
`21. Hammond ER, Kaplin AI, Kerr DA. Thalidomide for acute treatment of neurosarcoidosis.
`Spinal Cord. 2007; 45(12): 802-803.
`
`22. Pucak ML, Carroll KA, Kerr DA, Kaplin AI. Neuropsychiatric manifestations of depression
`in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the
`pathogenesis of immune-mediated depression. Dialogues in Clinical Neuroscience. 2007; 9(2):
`125-139.
`
`
`Par Pharm., Inc.
`Exhibit 1007
`Page 003
`
`

`

`4
`23. Graber JJ, Allie SR, Mullen KM, Jones MV, Wang T, Krishnan C, Kaplin AI, Nath A, Kerr
`DA, Calabresi PA. Interleukin-17 in transverse myelitis and multiple sclerosis. Journal of
`Neuroimmunology, 2008;196(1-2):124-132.
`
`24. Krishnan C, Kaplin AI, Brodsky RA, Drachman DB, Jones RJ, Pham DL, Richert ND, Pardo
`CA, Yousem DM, Hammond E, Quigg M, Trecker C, McArthur JC, Nath A, Greenberg BM,
`Kerr DA. Reduction of disease activity and disability with high-dose Cyclophosphamide in
`patients with aggressive multiple sclerosis. Archives of Neurology. 2008; 65(8): 1044-1051.
`
`25. Taylor J, Watkins C, Kaplin A. Kleine-Levin syndrome: A disease in its own right? Nature
`Clinical Practice Neurology. 2008; 4(10): 534-535.
`
`
`
`26. Kaplin A, Carroll KA, Cheng J, Allie R, Lyketsos CG, Calabresi P, Rosenberg PB. IL6
`Release by LPS-stimulated peripheral blood mononuclear cells as a potential biomarker in
`Alzheimer's Disease. International Psychogeriatrics. 2009; 21(2): 413-4.
`
`27. Trecker C, Kozubal D, Quigg M, Hammond E, Krishnan C, Sim P, Kaplin AI. Quality Care
`in Transverse Myelitis: A Responsive Protocol. Journal of Child Neurology 2009; 24(5): 577-83.
`
`28. Kaplin AI, Sedlak TW. Novel Neurotransmitters. Kaplan and Sadock’s Comprehensive
`Textbook of Psychiatry. 2009; 9th ed. 1: 102 –7
`
`29. Jamison KR, Wyatt RJ, Kaplin AI. The Patient’s Perspective. New Oxford Textbook of
`Psychiatry. 2009 2nd ed. 1: 3-4
`
`30. Hammoud, D. A., Endres, C. J., Hammond, E., Uzuner, O., Brown, A., Nath, A., Kaplin, A.,
`Pomper, M. Imaging serotonergic transmission with [11C]DASB-PET in depressed and non-
`depressed patients infected with HIV. NeuroImage. 2010;49(3):2588-2595. PMID: 19853044
`
`31. Kaplin AI and Stagg RE. Depression in Multiple Sclerosis. Multiple Sclerosis Therapeutics.
`2011 3rd ed. 825-44.
`
`32. Foreman AC, Hall C, Bone K, Cheng J, Kaplin A. Just Text Me: Using SMS Technology for
`Collaborative Patient Mood Charting. Journal of Participatory Medicine. 2011 Sep 26; 3: e45
`
`33. Kristen Rahn, Barbara Slusher, Kaplin, Adam I. Glutamate in CNS neurodegeneration and
`cognition and its regulation by GCPII inhibition. Current Medicinal Chemistry. 2012 Mar 1;
`19(9): 1335-45.
`
`35. Inhibition of Glutamate Carboxypeptidase II activity as a treatment for cognitive impairment
`in multiple sclerosis. Kristen A. Rahn, Crystal C. Watkinsa, Jesse Altb, Rana Rais, Marigo
`Stathis, Inna Grishkan, Ciprian M. Crainiceau, Martin G. Pomper, Camilo Rojas, Mikhail V.
`Pletnikov, Peter A. Calabresi, Jason Brandt, Peter B. Barker, Barbara S. Slusher, and Adam I.
`Kaplin. Proceedings of the National Academy of Sciences U S A. 2012 Dec 4; 109(49): 20101-6.
`
`36. Wong H, Bakare A, Benoit C, Wang J, Smith T, McCready SC, Guo H, Yu Q, Speed T,
`Kaplin AI. Evidence-based Medicine – Short Message Service Texting Ascertains Student Mood
`Fluctuations over the Winter Holiday Season. iHealth Connections. 2012; 2(1): 65-9.
`
`37. Kozubal DE, Samus QM, Bakare AA, Trecker CC, Wong HW, Guo H, Cheng J, Allen PX,
`Mayer LS, Jamison KR, Kaplin AI. Separate may not be equal: A preliminary Investigation of
`Clinical Correlates of Electronic Psychiatric Record Accessibility in Academic Medical centers.
`International Journal Medical Informatics. 2012 Dec 19; 82(4): 260-7
`38. Kristen A. Rahn, Ying-Jun Cao, Craig W. Hendrix, Adam I. Kaplin. The Role of 5-HT1A
`Receptors in Mediating Acute Negative Effects of Antidepressants: Implications in Pediatric
`Depression. Translational Psychiatry. 2015; 5(5). e563.
`
`
`
`
`
`
`
`Par Pharm., Inc.
`Exhibit 1007
`Page 004
`
`

`

`5
`
`
`39. Kristen A. Rahn, Barbara Slusher, Adam I. Kaplin. Cognitive Impairment in Multiple
`Sclerosis: A Forgotten Disability Remembered. Cerebrum. 2012; 14. Epub.
`
`39. Adam I. Kaplin, Laura Anzaldi. New Movement in Neuroscience: A Purpose-Driven Life.
`Cerebrum. 2015; 7.
`
`40. Kristen R. Hollinger, Jesse Alt, Alison Riehm, Barbara S. Slusher, Adam I. Kaplin. Dose-
`Dependent Inhibition of GCPII to Prevent and Treat Cognitive Impairment in the EAE Model of
`Multiple Sclerosis. Brain Research. 2016; 1635: 105-12
`
`41. Kristen R. Hollinger, Caroline Franke, Ana Arenivasa, Steven R. Woods, Maureen A. Mealy,
`Michael Levy, Adam I. Kaplin. Cognition, Mood, and Purpose in Life in Neuromyelitis Optica
`Spectrum Disorder. Journal of the Neurological Sciences. 2016; 362: 85-90.
`
`Patents/Applications
`
`9/14/07
`
`
`10/1/07
`
`3/17/08
`
`
`
`5/1/09
`
`
`7/11/09
`
`
`7/21/09
`
`
`7/21/09
`
`9/22/11
`
`
`12/14/11
`
`
`12/6/13
`
`Kaplin AI, Kerr DA. “Method of Identifying Patients Suitable for High-Dose
`Cyclophosphamide Treatment”Pending provisional patent application PCT/US07/78518
`filed 14-Sep-2007 JHU Ref. C05071
`
`Kaplin AI, Kerr DA. “Combined Treatment of CNS Autoimmune Diseases (e.g.
`Multiple Sclerosis) with Immunoablative Doses of Cyclophosphamide and Glatiramer
`Acetate to Immunize Against Autoimmune Disease Reactivation”
`Pending provisional patent application 60/997,074 filed 01-Oct-2007 JHU Ref. C10194
`
`Kaplin AI, Calabresi PA. “An Assay to Assess Aldehyde Dehydrogenase Activity from
`Adult Human Immune Cells to Predict the Dosing, Safety and Efficacy and Dosing of
`High-Dose Cyclophosphamide in the Treatment of Autoimmune Diseases”
`Pending provisional patent application 61/037,059 filed 17-Mar-2008 JHU Ref. C10332
`
`Brodsky R, Jones R, Kaplin AI. “Use of High-dose Oxazaphosphorine Drugs in
`Combination with Monoclonal Antibodies for Treating Immune Disorders”
`Pending provisional patent application 12/434,125 filed 01-May-2009 JHU Ref. C05098
`
`Kaplin AI.“Combined Treatment of CNS Autoimmune Diseases (eg. Multiple Sclerosis)
`with Immunoablative Doses of Cyclophosphamide and Antithymocyte Antibody
`Treatment (eg. Antithymocyte Globulin) to Achieve a Maximum Efficacy with Minimum
`Relapse Rate” Submitted for application 11-July-2009 JHU Ref. C10437
`
`Kaplin AI.“Methods for Treating or Preventing an Autoimmune Disease Comprising
`Administering Cyclophosphamide and ATG, Optionally in Combination with Glatiramer
`Acetate (Copaxone)”Submitted for application 21-July-2009 JHU Ref. C10814
`
`Kaplin AI, Worthington M. “Methods for Treating or Preventing an Autoimmune
`Disease Comprising Administering Cyclophosphamide and an Additional
`Immunomodulatory Agent” Submitted for application 21-July-2009 JHU Ref. C10815
`
`Kaplin AI. “Electronic System and Method for Patient Self-Assessment or Treatment
`Compliance” Submitted for application 22-September-2011
`
`Kaplin AI, Rahn K, Slusher B. Treatment of Cognitive Impairment in a Subject with a
`Neurological Autoimmune Disease, U.S. Patent Application No.: 13/994,514
`
`Kaplin AI, Rahn K- Preventing Suicidality and Impulsivity in Children and Adolescents
`when Initiating Antidepressant Therapy
`
`
`
`
`
`
`
`
`
`Par Pharm., Inc.
`Exhibit 1007
`Page 005
`
`

`

`
`
`
`
`
`
`
`
`
`
`Book Chapters and Reviews
`
`1. Voglmaier SM, Bembenek ME, Kaplin AI, Dorman G, Olszewski JD, Prestwich GD, Snyder
`SH. Purification and assay of inositol hexakisphosphate kinase and diphosphoinositol
`pentakisphosphate kinase. In S. Shears (Ed.), Signaling by Inositides: A Practical Approach.
`1997; Oxford: IRL Press at Oxford University Press.
`
`6
`
`2. Kerr DA, Krishnan C, Kaplin AI, Deshpande DM, and Pardo CA. Transverse Myelitis:
`Clinical Manifestations, Pathogenesis, Management. Inflammatory Disorders of the Nervous
`System: Pathogenesis, Immunology and Clinical Management. Eds: A. Minagar and J.S.
`Alexander. Humana Press. (Book chapter). 2004.
`
`3. Kaplin, AI. Review of: Neurological and Psychiatric Disorders: From Bench to Bedside.
`Doody's Review Service (on-line). Available: http://www.doody.com. 2005.
`
`4. Kaplin, AI. Editor: International Review of Psychiatry: At the Nervous and Immune Systems’
`Interface: the Effects of Inflammation on Thoughts, Feelings and Behaviors, 2005, 17(6).
`
`5. Kaplin, AI. Depression In Multiple Sclerosis. Multiple Sclerosis Therapeutics, Third Edition.
`Eds: J.A. Cohen and R.A. Rudick. Informa Healthcare. (Book chapter). 2007.
`
`6. Kaplin, AI, Carroll, KA. Multiple Sclerosis. Psychiatric Aspects of Neurologic Diseases:
`Practical Approaches to Patient Care. Eds: C.G. Lyketsos, P.V. Rabins, J.R. Lipsey, P.R.
`Slavney. Oxford University Press. (Book chapter). 2008.
`
`7. Kaplin AI and Sedlak TW. Novel Neurotransmitters: Nitric Oxide and beyond. Kaplan &
`Sadock’s Comprehensive Textbook of Psychiatry, 9th Edition, Eds: B.J. Sadock, V.A. Sadock, P.
`Ruiz. Lippincott Williams & Williams. (Book Chapter). 2009.
`
`8. Jamison, K R, Wyatt, R J, and Kaplin, AI. The patient’s perspective. Oxford Textbook of
`Psychiatry. Oxford: Oxford University Press. 2009.
`
`9. Trecker C, Kozubal D, Kaplin AI, Kerr DA. Transverse Myelitis: Pathogenesis, Diagnosis,
`and Management. In C. Lucchinetti (Ed.), Multiple Sclerosis 3 (Blue Books in Neurology).
`Elsevier Health Sciences. 2009.
`
`10. Kaplin, AI, Stagg, R. Depression in Multiple Sclerosis. Multiple Sclerosis Therapeutics,
`Fourth Edition. Eds: J.A. Cohen, R.A. Rudick. Cambridge University Press. (Book Chapter).
`2011.
`
`Other Media
`
`
`Televison/Internet
`
`Kaplin AI. “Multiple Sclerosis: How Does One Cope With It?” Interview With Montel
`Williams, 2006 and 2008.
`
`Nancy Davis, Stephen Hauser, Adam Kaplin, Mark Barondess. Broadcast on CNN Larry King
`Live, March 6, 2004.
`
`Adam Kaplin and Daniel Becker, Sanjay Gupta on CBS Evening News, SCUBA Study in
`Chronic Paralyzed Veterans. 2011.
`
`
`Par Pharm., Inc.
`Exhibit 1007
`Page 006
`
`

`

`HuffPost Live Video Segment, Discussant about eHealth and Apps. 10/16/12
`
`
`EDUCATIONAL ACTIVITIES AND SELECTION OF RECENT TALKS
`
`
`7
`
`Teaching
`
`Dec 2007-Jan 2009
`
` Post Doctoral Bioethics Seminar, Seminar Leader, Johns Hopkins Medicine, Department
`of Psychiatry.
`
`
`Feb 2009-April 2010 Becoming a Successful Scientific Faculty Member, Seminar Leader, Johns Hopkins
`Medicine, Department of Psychiatry.
`
`
`Feb 2007-Present
`
`
`May 2010-Present
`
`
`2010- Present
`
`
`2013
`
`
`2014
`
`
`2014
`
`
`2014
`
` Medical Student Psychiatry Course, Instructor, Johns Hopkins Medicine, Department of
`Psychiatry and Behavioral Sciences.
`
`How Science is Really Done. A Personal Account from Successful Scientists, Seminar
`Leader, Johns Hopkins Medicine, Department of Psychiatry.
`
`T32 Seminar: Ethics, Morbidity, and Mortality, Course Director, Johns Hopkins
`Medicine, Department of Psychiatry.
`
`Invited Grand Rounds Speaker, Johns Hopkins Health Science Informatics Department,
`MENTAL HEALTH INFORMATION TECHNOLOGY, Fri, 11/08/2013
`
`Mood24/7 selected to be presented at the eHealth Executive Summit 2014 sponsored by
`the Atlantic Magazine and the National Council on Behavioral Health.
`
`Keynote Speaker at the Annual meeting of the National Network of Depression Centers
`(www.nndc.org) where I spoke on the topic of Technological Applications in Clinical
`Care- Where Are We Now?
`
`Invited to present at the White House conference organized by ONDCP & SAMHSA title
`"Technology Innovations for Substance Abuse and Mental Health Treatment" taking
`place on September 16, 2013 at the Eisenhower Executive Office Building.
`
`
`Mentoring
`
`Dana Kozubal, Research Coordinator, currently MS-3 at U Penn Medical School
`2008-2009
`2008-2009
`Carrie Trecker, Research Coordinator, currently a graduate of Drexel PA School
`2009-2010
`Ying Guo, Research Coordinator, currently MS-1 at Nebraska Medical School
`2009-2010
`Hei-Wah Wong, Research Coordinator, currently MS-2 at Sinai Medical School
`2009-2011
`Keiko Furukori, graduate student, currently a Post-doc at Yale University
`2009-2011
`Crystal Watkins, currently an Assistant Professor at Johns Hopkins
`2010-2011
`Jeffery Cheng, research coordinator, currently MS-1 at Albert Einstein Medical School
`2010-Present Kristen Rahn, currently a T32 Postdoctoral Student to be promoted to instructor after 2012
`
`
`Instrumental in obtaining Acetylon, R21, and National MS Society grants
`2010-Present Anisha Contractor, currently an Undergraduate Researcher
`2011-Present Ryan Stagg, currently Junior Faculty and a PGYIV Resident
`2011-Present Vicki Kalira, currently a PGYIII Resident
`2011-Present Michele Carras, currently a PGY1 Mental Health Student
`2011-Present Anu Bakare, currently a Research Coordinator
`2011-Present Alison Riehm, currently a Lab Technician
`2011-Present Mohammed Umair Malik, currently a Post-doc Fellow
`
`CLINICAL & ADVISORY ACTIVITIES
`
`
`Par Pharm., Inc.
`Exhibit 1007
`Page 007
`
`

`

`Certification
`
`1998-Present Medical License, State of Maryland, License #: D00540054, Exp Date: 9/30/2016
`
`8
`
`Boards
`
`2002-Present International Transverse Myelitis Association Medical Advisory Board Member
`
`2003-Present Montel Williams MS Foundation Chairman of Scientific Advisory Board
`
`2004-2008
`
`National Multiple Sclerosis Society (NMSS) Task Force on Epidemiology
`Member, Appointed by the Montel Williams MS Foundation.
`
`2004-Present Johns Hopkins Project RESTORE Faculty Member
`
`Member of the Scientific Advisory Council and Operating Committee.
`
`2004-Present Johns Hopkins GCRC Adult Protocol Review Subcommittee (PRS)
`
`2004-Present Young Leaders Forum for the National Committee on United States-China Relations
`Member; one of four New Fellows invited each year, recognized by home country
`for accomplishments, outstanding leadership potential, and strong interest in Civic
`and International Affairs.
`
`2006-Present
`
` 2006 Young Leader of the French-American Foundation
`
`2013-Present Invited Global mHealth Initiative Steering Committee member in the JHBSPH
`
`SYSTEM INNOVATION AND QUALITY IMPROVEMENT ACTIVITIES
`
`Inventor and Co-Developer of Mood24/7, an SMS-Internet Based system to monitor patient’s daily mood,
`serve as an electronic health diary, and coordinate care between health care providers. Currently being
`used across the country (over 10,000 individuals registered) and on several grants, Pfizer signed contract
`with JHM to employ in Drug Trial, KKI plans to implement in the department of behavioral health to
`collect outcomes data, and NNDC is planning ways to implement in studies of mood disorders.
`
`Integrated Mental Health Care and Research into the Johns Hopkins MS and TM Centers. I also provide a
`weekly Neuropsychiatric Consultation Clinic for CNS Autoimmune Diseases and have patients who
`come from all over the US, and as far away as Dubai and Bahrain to receive ongoing care. To my
`knowledge I am the only psychiatrist who specializes in the psychiatric aspects of MS on the East Coast.
`
`RECOGNITION
`
`Awards
`
`1989-1996
`
`Medical Scientist Training Program Award
`
`1998
`
`
`
`NIH/NIMH Outstanding Resident of the Year Award
`Special Achievement as a Resident in Psychiatry
`
`2000
`
`2002
`
`Pfizer Resident of the Year 2000 Award in Psychiatry
`
`Future Leaders in Psychiatry Award, Emory University
`
`2003-2005
`
`The Johns Hopkins School Of Medicine Clinician Scientist Career
`Development Awards
`
`Par Pharm., Inc.
`Exhibit 1007
`Page 008
`
`

`

`9
`
`2004-Present Young Leaders Forum for the National Committee on United States-China
`Relations
`
`2006-Present Young Leader of the French-American Foundation
`
`
`
`2012
`
`2013
`
`2015
`
`Baltimore Magazine Top Psychiatrist for 2012
`
`Inaugural Elsevier Clinical Keys Innovator Award 2013
`
`PM360 ELITE Tech-Know Geek Awardee.
`
`Par Pharm., Inc.
`Exhibit 1007
`Page 009
`
`